Ricevi le ultime notizie sulle azioni Abbott Laboratories con aggiornamenti su tendenze di mercato, dati finanziari e analisi di Benzinga. Rimani informato sulle performance di ABT

Ultime notizie per

ABBOTT LABORATORIES

Abbott Laboratories

Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.

Massachusetts,,Usa,-,26,July,2024.,Bank,Of,America,Logo

Earnings

Equities

Markets

ASML

PZZA

Report finanziari e annunci societari: una guida ai titoli che promettono alta volatilità e opportunità di trading nelle prossime ore.

Previsioni utili: Bank of America, Morgan Stanley e altre 3 azioni da tenere d&#39;occhio oggi

Oct,15,,2019,Sunnyvale, - ,Ca, - ,Usa,-,Close

News

Pre-Market Outlook

Trading Ideas

JBHT

Apertura USA attesa in rosso. In arrivo conti trimestrali chiave, focus sulle reazioni del mercato ai dati societari pubblicati.

5 titoli da monitorare oggi: tra attese sugli utili e reazioni post-conti

Long Ideas

Media

CWST

SOFI

Jim Cramer su uno specifico titolo, con dettagli sulle ragioni dietro la sua valutazione e le implicazioni per gli investitori.

Jim Cramer lancia l&#39;allarme su questo titolo: ecco perché è preoccupato

American Bitcoin Corp. - Class A Common Stock

American Bitcoin Corp

Arcblock - United States dollar

Abits Group Inc

ALTEROLA BIOTECH INC by Alterola Biotech, Inc.

Alterola Biotech Inc

AB&T Financial Corp Com

ABOITIZ EQTY VNT UNSP/ADR by Aboitiz Equity Ventures, Inc.

Aboitiz Equity Ventures Inc

Small Cap

Opinion

Press Releases

Artificial Intelligence Revolutionizing Early Detection of Diabetic Retinopathy Creating a Multi-Billion Dollar Revenue Opportunity

Ainnova Tech Reaches Major FDA Milestone in AI-Powered Diabetic Retinopathy Detection

Abbott Reports Second-Quarter 2025 Results

Abbott and Big Ten Conference Rally Students, Alumni, and Fans to Save Lives and Win $1 Million for Their School by Donating Blood This College Football Season

NYSE Content Advisory: Pre-Market update + Wall Street braces for Nvidia's earnings

Abbott's Navitor™ TAVI System Receives CE Mark for Expanded Indication to Treat More People With Aortic Stenosis

Dividends

Abbott Declares 407th Consecutive Quarterly Dividend

Abbott Hosts Conference Call for Third-Quarter Earnings

Abbott's Dissolving Stent Receives Health Canada Approval for Treating Blocked Arteries Below-the-Knee

Abbott Reports Third-Quarter 2025 Results and Reaffirms Full-Year Guidance

AVAI

DXCM

IRTC

TNDM

Baxter Intl

Becton, Dickinson and Company Common Stock

Becton Dickinson

Boston Scientific Corporation Common Stock

Boston Scientific

DexCom

Edwards Lifesciences Corporation Common Stock

Edwards Lifesciences

GE HealthCare Technologies Inc. - Common Stock

GE HealthCare Techs

Glaukos

Globus Medical, Inc. Class A Common Stock

Globus Medical

Hologic

IDEXX Laboratories

iRhythm Technologies, Inc. - Common Stock

iRhythm Technologies

Intuitive Surgical

Integer Holdings Corporation Common Stock

Integer Holdings

Masimo

Medtronic

Penumbra

Koninklijke Philips N.V. NY Registry Shares

Koninklijke Philips

Insulet

ResMed

Smith & Nephew

Steris

Stryker

Teleflex

TransMedics Group

Zimmer Biomet Holdings, Inc. Common Stock

Zimmer Biomet Holdings

Evercore ISI Group

RBC Capital

Wells Fargo

BTIG

Benchmark

Screenshot 2025-02-24 at 11.35.34 PM

Biotech

General

BRTX

BioRestorative Therapies Receives FDA Fast Track Approval For BRTX-100 To Treat Chronic Lumbar Disc Disease

Screenshot 2025-02-24 at 6.22.23 PM

GCTK

Glucotrack Commences Transition From Concept To Reality With Breakthrough Clinical Trial

Screenshot 2024-12-03 at 7.43.04 PM

Driving Innovation In Diabetes Management: Glucotrack Begins Enrollment For Human Clinical Trials For Its Implantable Continuous Blood Glucose Monitor

Screenshot 2024-10-03 at 5.30.47 PM

Health Care

SENS

Expanding Continuous Glucose Monitoring Options: How Glucotrack Is Helping Usher In The Next Generation Of Diabetes Care Technology

Movers & Shakers

Continuous Blood Glucose Monitoring Can Materially Improve The Quality Of Life For People With Diabetes – Glucotrack Wants To Make It Easier

Comments

Abbott Laboratories Notizie sulle azioni

Notizie

Ultime notizie per

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO